Default company panoramic image
14255d27 fc64 4455 8900 b73a6dbaa1b2

Freencer Labs, LLC

Disruptive components for efficient anti-metastatic immunotherapy vaccines for cancer with cancer stem cells and anti-suppression technologies.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded 2012
  • Employees 2
  • Website

Company Summary

Our mission is to commercialize and significantly improve efficacy of immunotherapy vaccines by delivering disruptive components allowing for prevention of metastases and un-blocking of suppressed anti-tumor response by immune cells.


  • Annag

    Strategized the commercialization of immunotherapy vaccines and cancer stem cells products; studied cancer metabolism and bioenergetics; software engineer; book author; patient advocate; cancer survivor.